登录 | 注册    关注公众号  
微信公众号
搜索
 > 【VEGF R1】

VEGF R1信息

英文名称:Vascular endothelial growth factor receptor 1
中文名称:血管内皮细胞生长因子受体1
靶点别称:Fms Related Receptor Tyrosine Kinase 1,EC 2.7.10,EC:2.7.10.1,VEGFR1,Tyrosine-protein kinase receptor FLT,FRT,Fms-like tyrosine kinase 1,FLT1,Fms Related Tyrosine Kinase 1,Vascular Permeability Factor Receptor,Fms-Related Tyrosine Kinase 1 (Vascular Endothelial Growth Factor/Vascular Permeability Factor Receptor),Vascular Endothelial Growth Factor Receptor 1,Tyrosine-Protein Kinase FRT,VEGFR-1,FLT-1,FLT,Fms-Related Tyrosine Kinase 1,EC 2.7.10.1,Vascular Endothelial Growth Factor Receptor-1
上市药物数量:12
临床药物数量:16
最高研发阶段:批准上市

VEGF R1分子别名

FLT,VEGFR1,FLT1

VEGF R1分子背景

Vascular endothelial growth factor receptor 1 (VEGFR1) is also known as Fms-like tyrosine kinase 1 (FLT-1), Tyrosine-protein kinase receptor FLT, is a single-pass type I membrane protein and secreted protein which belongs to the protein kinase superfamily, Tyr protein kinase family and CSF-1/PDGF receptor subfamily. VEGFR1 is detected in normal lung, but also in placenta, liver, kidney, heart and brain tissues and specifically expressed in most of the vascular endothelial cells, and also expressed in peripheral blood monocytes. VEGFR1 acts as a cell-surface receptor for VEGFA, VEGFB and PGF, and plays an essential role in the development of embryonic vasculature, the regulation of angiogenesis, cell survival, cell migration, macrophage function, chemotaxis, and cancer cell invasion. VEGFR1 may play an essential role as a negative regulator of embryonic angiogenesis by inhibiting excessive proliferation of endothelial cells. VEGFR1 can promote endothelial cell proliferation, survival and angiogenesis in adulthood.

VEGF R1上市药物信息

英文名称 中文名称 研发代码 研发阶段 公司 最早商品名 最早批准国家 最早适应症 最早批准公司 最早批准日期 适应症 临床试验

VEGF R1临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验

消息提示

请输入您的联系方式,再点击提交!

确定